Recruiting

Mobile Health

Sponsor:

Children's Hospital of Philadelphia

Code:

NCT06642246

Conditions

Insufficient Sleep

Hypertension

Eligibility Criteria

Sex: All

Age: 13 - 18

Healthy Volunteers: Not accepted

Interventions

Intervention

Study Details

Brief summary:

Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

Conditions

Insufficient Sleep

Hypertension

Study ID

NCT06642246

Start date

Feb 16, 2026

Status verified date

Aug, 2026

Completion date

Nov, 2026

Anticipated

Primary completion date

Nov, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 13 - 18

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Speak, read and write in English.
  • Parental/guardian permission (informed consent) and child assent.
  • Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
  • Parent reported sleep duration on school nights less than or equal to 7.5 hours.
  • Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM).
  • If taking over the counter sleep aides, willing to stop them over the course of the study.

Exclusion Criteria:

  • Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
  • Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).

Inclusion Criteria for Parents/Legal Guardians:

  • Be the parent/guardian of an eligible child enrolled in the main study.
  • Speak, read, and write in English.

Exclusion Criteria for Parents/Legal Guardians:

\- Limited English proficiency

Study Design

Enrollment

10 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Arm 1

Sleep goal, Sleep guidance messaging, Loss-framed incentive, Supportive feedback.

Interventions

Intervention

During a 7-week intervention phase, parent-child dyads will be provided a sleep duration goal paired with a loss-framed financial incentive (virtual account) starting with deductions each time the sleep goal is not met, will be sent sleep guidance text messages, and will receive weekly performance feedback text messages.

Primary outcome measure

  • Hypertension [ Time Frame: From baseline to approximately week 11 ]
  • Change in sleep tracker estimated weeknight sleep duration [ Time Frame: From baseline to approximately week 11 ]

Central Contacts and Locations

Central contacts

Jonathan Mitchell

267-426-1473mitchellj2@chop.edu

Abby Salem

215-590-2386salema1@chop.edu

Locations

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19146

Contacts

Jonathan Mitchell

267-426-1473mitchellj2@chop.edu

Abby Salem

215-590-2386salema1@chop.edu

Principal Investigator:

Jonathan Mitchell, PhD

More Information

Sponsor

Children's Hospital of Philadelphia

Last update posted

Aug 28, 2026

Last verified

Aug, 2026

Keywords

  • Insufficient Sleep
  • Hypertension

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital of Philadelphia on 2026-08-28.